mail2

Spectrum Library

Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders

Publication Date March 2020

Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry

Publication Date October 2019

The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began.

Publication Date December 2019

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.

Publication Date August 2019

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

Publication Date September 2019

Early B cell tolerance defects in NMO favour anti-AQP4 autoantibody production

Publication Date June 2019

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Publication Date April 2019

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Publication Date April 2019

Rituximab in neurological disease: principles, evidence and practice.

Publication Date November 2018

MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response

Publication Date July 2018

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

Publication Date May 2018

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness

Publication Date May 2018

Tags
Recent Comments